Intrarenal angiotensin II (Ang II), a principal effector of the RAS that is increased in DN, acts through 2 major angiotensin receptors, Ang II type I receptor (AT1R) and AT2R, and may be involved in dysfunctional responses in the diabetic kidney [3–5]. This evidence concerns the gene AGTR1 and liver dysplastic nodule.